Table 1.
Baseline Demographics
| Characteristic | Safety population n=26 | ITT population sequence 1 placebo/MPH-MLR n=11 | ITT population sequence 2 MPH-MLR/placebo n=11 | ITT population n=22 |
|---|---|---|---|---|
| Mean (SD) age, y | 8.7 (1.9) | 8.9 (1.9) | 8.7 (1.9) | 8.8 (1.9) |
| Male, n (%) | 14 (54) | 6 (55) | 6 (55) | 12 (55) |
| Race, n (%) | ||||
| White | 21 (81) | 9 (82) | 9 (82) | 18 (82) |
| Black | 3 (12) | 2 (18) | 0 (0) | 2 (9) |
| Asian | 1 (4) | 0 (0) | 1 (9) | 1 (5) |
| Other | 1 (4) | 0 (0) | 1 (9) | 1 (5) |
| Hispanic or Latino ethnicity, n (%) | 6 (23) | 3 (27) | 2 (18) | 5 (23) |
| Mean (SD) weight, kg | 33.7 (12.0) | 37.9 (15.1) | 30.7 (8.9) | 34.3 (12.6) |
| Mean (SD) height, cm | 135.9 (12.8) | 139.2 (13.7) | 133.4 (11.2) | 136.3 (12.5) |
ITT, intent-to-treat; MPH-MLR, extended-release multilayer bead methylphenidate.